GR861529B - 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases - Google Patents

1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases

Info

Publication number
GR861529B
GR861529B GR861529A GR860101529A GR861529B GR 861529 B GR861529 B GR 861529B GR 861529 A GR861529 A GR 861529A GR 860101529 A GR860101529 A GR 860101529A GR 861529 B GR861529 B GR 861529B
Authority
GR
Greece
Prior art keywords
treatment
cardiovascular diseases
derivatives used
dihydropyridine derivatives
dihydropyridine
Prior art date
Application number
GR861529A
Other languages
English (en)
Inventor
Sircar Ila
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of GR861529B publication Critical patent/GR861529B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
GR861529A 1985-06-17 1986-06-12 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases GR861529B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74596585A 1985-06-17 1985-06-17
US85273186A 1986-04-21 1986-04-21

Publications (1)

Publication Number Publication Date
GR861529B true GR861529B (en) 1986-10-14

Family

ID=27114542

Family Applications (1)

Application Number Title Priority Date Filing Date
GR861529A GR861529B (en) 1985-06-17 1986-06-12 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases

Country Status (12)

Country Link
EP (1) EP0206747B1 (el)
KR (1) KR900005024B1 (el)
AU (1) AU601946B2 (el)
CA (1) CA1267416A (el)
DE (1) DE3675271D1 (el)
DK (1) DK281186A (el)
ES (1) ES8800904A1 (el)
FI (1) FI862343A (el)
GR (1) GR861529B (el)
NO (1) NO862390L (el)
NZ (1) NZ216555A (el)
PT (1) PT82766A (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601382D0 (en) * 1986-01-21 1986-02-26 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
GB8526411D0 (en) * 1985-10-25 1985-11-27 Pfizer Ltd Dihydropyridines
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
IT1215381B (it) * 1987-03-12 1990-02-08 Boehringer Biochemia Srl Farmaceutiche che le contengono. carbonil- e solfonil- derivati di 2-(aminoalchiltio)metil-1,4-diidropiridine, un metodo per la loro preparazione e composizioni
DE3732380A1 (de) * 1987-09-25 1989-04-06 Bayer Ag Dihydropyridinether, verfahren zu ihrer herstellung und ihre verwendung
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2239815C2 (de) 1972-08-12 1983-02-10 Bayer Ag, 5090 Leverkusen 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2242786A1 (de) 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
DE2248150A1 (de) 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2335466A1 (de) 1973-07-12 1975-01-30 Bayer Ag Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
BE843576A (fr) 1975-04-03 1976-12-29 Derives de 1,4-dihydropyridine et leur procede de preparation
GB1591089A (en) 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3130041A1 (de) 1981-07-30 1983-02-17 Bayer Ag, 5090 Leverkusen Dihydropyridine mit positiv inotroper wirkung, neue verbindungen, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
DE3239273A1 (de) 1982-10-23 1984-04-26 Bayer Ag, 5090 Leverkusen Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
GR851819B (el) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
EP0200524A3 (en) 1985-05-03 1987-06-16 Pfizer Limited Dihydropyridine calcium antagonists

Also Published As

Publication number Publication date
ES556082A0 (es) 1987-12-01
KR870000298A (ko) 1987-02-17
NZ216555A (en) 1989-01-06
NO862390D0 (no) 1986-06-16
NO862390L (no) 1986-12-18
PT82766A (en) 1986-07-01
FI862343A0 (fi) 1986-06-02
AU601946B2 (en) 1990-09-27
EP0206747B1 (en) 1990-10-31
FI862343A (fi) 1986-12-18
EP0206747A3 (en) 1987-08-19
DK281186D0 (da) 1986-06-16
AU5842886A (en) 1986-12-24
ES8800904A1 (es) 1987-12-01
EP0206747A2 (en) 1986-12-30
DK281186A (da) 1986-12-18
CA1267416A (en) 1990-04-03
DE3675271D1 (de) 1990-12-06
KR900005024B1 (ko) 1990-07-18

Similar Documents

Publication Publication Date Title
JPS6450858A (en) Manufacture of 2,2,6,6-tetramethyl-4- piperidylamine
KR950010075B1 (en) Process for the preparation of 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives
DE3662256D1 (en) Process for the preparation of (2,2)-paracyclophane
PL268618A1 (en) The method of manufacture of 1,4-dihydropyridine derivatives
DE3569375D1 (en) Process for the preparation of 1,2-benzisothiazolones
PH23723A (en) Novel 1,8-naphthyridine derivatives
EP0200391A3 (en) Substituted 2,3,4,9-tetrahydro-1h-carbazole-1-acetic acid derivatives
GR861529B (en) 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases
EP0371492A3 (en) Process for the preparation of 1,4-dihydropyridine derivatives
EP0206147A3 (en) Process for the preparation of 4,4'-dinitrodibenzyls
PT83636A (en) Process for the preparation of 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones
PT83884A (en) Process for the preparation of 1 azolyl-3,3-dimethyl-tutan-2-on-and-ol derivatives
CY1760A (en) Process for the preparation of 1,4-dihydropyridine derivatives
HU9202873D0 (en) 1,4-dihydropyridine derivatives of paf-antagonistic effect
PT83799A (en) Process for the preparation of novel 2,2:-bi-1h-imidazoles
GR861895B (en) Process for the preparation of 3,7-disubstituted-3-cephem compounds
EP0198795A3 (en) Process for the preparation of 1,4-diaminoanthraquinones
ZA863914B (en) 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
IL85037A0 (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives
EP0206293A3 (en) Process for the preparation of 3,5-dichloro-2-pyridone
EP0258815A3 (en) Derivatives of 2,2-dimethyl-cyclopropanecarboxylic acid derivatives of 2,2-dimethyl-cyclopropanecarboxylic acid
ZA874768B (en) New use of 1,4-dihydropyridine derivatives
DE3662784D1 (en) Process for the preparation of 1,3,6,8-tetrabromopyrene
ZA885123B (en) Pest-combating agents based on derivatives of 2,3-diaminomaleonitrile
PT83635A (en) Process for the preparation of 5-naphthyl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones